PlainRecalls
FDA Drug Moderate Class II Terminated

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

Reported: October 14, 2015 Initiated: September 23, 2015 #D-0006-2016

Product Description

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

Reason for Recall

Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.

Details

Units Affected
129 vials
Distribution
KY, OH, TN
Location
Franklin, TN

Frequently Asked Questions

What product was recalled?
Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527. Recalled by Diabetes Corporation of America dba DCA Pharmacy. Units affected: 129 vials.
Why was this product recalled?
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 14, 2015. Severity: Moderate. Recall number: D-0006-2016.